Efficacy of Tranexamic Acid Versus Topical 4% Hydroquinone in Melasma
Phase 3
- Conditions
- Melasma ..L81.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM L81.1 became effective on October 1, 2021.This is the American ICD-10-CM version of L81.1 - other internationalL81.1
- Registration Number
- IRCT20220709055422N1
- Lead Sponsor
- Pak-Emirates Military Hospital Rawalpindi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 290
Inclusion Criteria
patients suffering from melasma
Exclusion Criteria
history of discoid lupus erythematosus
pregnancy
lactation
anemia
oral contraceptives or hormone replacement therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy was evaluated on the basis of fall in MASI score for Melasma from base line. Timepoint: Interventions were Offred for a period of 12 weeks. Follow up was done at 4 weekly intervals for 12 weeks. After 12 weeks final response was assessed. All patients were called for follow up and efficacy was evaluated on the basis of fall in MASI score from base line. Method of measurement: MASI score was measured by a trained physician on each visit.
- Secondary Outcome Measures
Name Time Method